PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25683972-8	2015	Compared with placebo, treatment with FCM was associated with an increase in eGFR [treatment effect: week 4, 2.11 +- 1.21 (P = 0.082); week 12, 2.41 +- 1.33 (P = 0.070); and week 24, 2.98 +- 1.44 mL/min/1.73 m(2) (P = 0.039)].	ferric carboxymaltose	38-41	CD59 molecule (CD59 blood group)	Homo sapiens	199-204